Clinical trial
18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety
NCT03042416
Study timeline
Study start (actual)2017-06-29Date precision: day
Registry last updated2022-01-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Congenital Hyperinsulinismunresolved
Neuroblastomaunresolved
Neuroendocrine Tumorsunresolved
Parkinson Diseaseunresolved
Brain Gliomaunresolved
Interventions
18F-DOPADRUG
Sponsors & collaborators
University of Albertalead sponsor
Alberta Health servicescollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03042416 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.